lp-a.org

Testing

Lp(a) predicts long-term aortoiliac stent failure in a post hoc analysis of the COBEST trial (J Cardiovasc Dev Dis 2026)

Original title: Lipoprotein(a) and Triglycerides as Independent Predictors of Long-Term Aortoiliac Stent Failure After Endovascular Revascularisation

J Cardiovasc Dev Dis · · 6

Mwipatayi BP, Lee BJ, Dauda D, Dodd JE, Mwipatayi MT, Golledge J, Mori TA, Watts GF, Schlaich MP

This post hoc biomarker analysis of the COBEST randomised trial evaluated baseline lipoprotein(a) as a predictor of long-term restenosis or occlusion after aortoiliac stenting in 125 patients. Cox proportional hazards modelling showed that each 1 mg/dL higher Lp(a) concentration was independently associated with a higher hazard of primary patency loss (HR, 1.08; 95% CI, 1.06-1.10; p < 0.001). The association persisted in biomarker-adjusted models and translated to an HR of 2.16 per 10 mg/dL increase. While the findings reinforce Lp(a) as a residual vascular risk marker in peripheral interventions, the post hoc design and modest sample size limit causal inference and clinical application.

Read the paper (DOI)PubMed

Original abstract

Background: Restenosis and occlusion remain important after aortoiliac stenting, and device choice does not fully explain late patency loss. Lipoprotein(a) [Lp(a)] is implicated in atherosclerotic progression and residual vascular risk.

Objective: To determine whether baseline Lp(a) is associated with long-term restenosis or occlusion after aortoiliac stenting.

Methods: This post hoc biomarker analysis of COBEST included 125 patients and 168 treated iliac arteries randomised to the Advanta V12 covered stent (Atrium Medical Corporation, Hudson, NH, USA) or bare-metal stents for symptomatic aortoiliac occlusive disease. The primary outcome was loss of primary patency, defined as restenosis or occlusion during 5-year follow-up. Cox proportional hazards modelling and cumulative failure curves were the main analyses.

Results: In the Lp(a)-adjusted Cox model, covered stent use was associated with a lower hazard of restenosis or occlusion (HR, 0.55; 95% CI, 0.31-0.97; p = 0.039), whereas each 1 mg/dL higher Lp(a) concentration was associated with a higher hazard (HR, 1.08; 95% CI, 1.06-1.10; p < 0.001; equivalent to HR, 2.16; 95% CI, 1.79-2.59 per 10 mg/dL increase). In the biomarker-adjusted model, each 1 mg/dL higher Lp(a) concentration (HR, 1.05; 95% CI, 1.02-1.08; p < 0.001; HR, 1.63; 95% CI, 1.22-2.16 per 10 mg/dL increase) and each 1 mmol/L higher triglyceride concentration (HR, 1.89; 95% CI, 1.34-2.68; p < 0.001) remained associated with restenosis or occlusion.

Conclusions: Elevated Lp(a) and, to a lesser extent, triglycerides were independently associated with long-term aortoiliac stent failure after adjustment for stent type.

riskrisk predictiontestingtrials

Summary written by lp-a.org from the published abstract; figures as published. Page updated 31 October 2026. Methods.